You are on page 1of 2

Subscribe to

NexantThinking
Special Report: Biorenewables Financing Under the Microscope
Report Overview
Subjects addressed:

Types of ventures receiving financing


--

By Market Sub-Sectors

--

By Technology Type

--

Regions/countries

--

By Financing Type

Financing mechanisms available at different stages


of commercialization

private equity, investments by public and private companies,


acquisitions, joint ventures, government policies and grants,
subsidies, government loan guarantees, IPOs, bond and debt
financing and strategic partnerships.
Different financing mechanisms are appropriate at different
stages of commercialization. Each financing mechanism has
its own pros and cons in overcoming hurdles typically faced by
companies on the path to commercialization. The financing
decision greatly impacts success or failure.

Amounts financed by each mechanism

The report, Biorenewables Financing Under the Microscope


will address the topic of how biorenewables ventures succeed
and fail, and answer the following questions:

Pros and Cons of each mechanism

Trends in financing

Hurdles faced in commercializing biorenewables


-

By companies

By investors

Case studies of success and failure

What types of ventures are receiving financing?


--

Which technologies and market sectors are receiving


the most attention?

What are the different financing mechanisms available?


--

How much financing is being received?

--

What are the pros and cons?

Financing decisions as a driver of success or failure

Broad concerns about the economics of petroleumbased feedstocks, the future of the global economy and
the environment have forced industries, consumers
and governments to pursue avenues to reduce reliance
on fossil fuels and petrochemicals. Consequently,
some of the worlds biggest players in the energy and
petrochemical industry are seeking to develop new
feedstocks and bio-based chemicals and fuels. This
trend has also fostered efforts of a number of startups to
commercialize innovative technologies to produce these
biorenewables.

What are the hurdles faced in commercializing


biorenewables by companies and investors?

How can financing decisions drive success or failure?

Biorenewables ventures typically face greater


hurdles than petrochemical ventures on the path to
commercialization. The path to commercialization for
biorenewables is typically more complex, considering the
necessity to prove performance and cost-competitiveness
of these new, innovative technologies at a scale
comparable to that of petrochemicals and fossil fuels.
The nature of this process necessitates a significant
infusion of capital at each stage of development to ensure
success. Obtaining financing is critical to the success of
these ventures.
There are various mechanisms available to finance
biorenewables ventures. Investment and support for
this industry has come in the form of venture capital,

The planned study will give subscribers a solid background


on global developments in biorenewables (excluding food,
agricultural, and pharmaceuticals) investment, financing, and
industry directionality. Nexant will analyze which specific
subsectors of biorenewables and technologies are receiving
attention. Nexant will utilize its extensive network of primary
and secondary resources to produce unique industry insights
into the challenges faced in commercializing biorenewables,
with a dissection of investments made, as well as case studies
of success and failure.
Nexant has assisted in numerous significant biorenewables
techno-economic and financial due diligences, investments,
financing, acquisitions, IPOs and joint ventures, which is an
invaluable touchstone for the proposed analysis. Nexants
multi-client report will be useful to those private and government
organizations, either providing or seeking financing, and
wishing to understand how companies can make use of the
different financing mechanisms available to them to successfully
commercialize biorenewables.
For information regarding the upcoming Biorenewables
Financing Under the Microscope report, please contact
STMC@nexant.com.

NexantThinking Programs provide subscribers and users with comprehensive analytics,


forecasts and insights for the energy, chemicals, polymers and clean tech industries
For more information, please visit us at: http://thinking.nexant.com

NexantThinking

The future of energy and chemicals

NexantThinking is a suite of advisory


services and products with exclusive
focus on the energy, chemicals and
related industries. This includes a
portfolio of multiclient programs,
formerly known as ChemSystems,
which provides comprehensive
reports, analysis and planning tools
to support decision making with a
focus on markets, economics and
technology.
Global in scope, Nexant serves its
clients from over 30 offices located
throughout the Americas, Europe, the
Middle East, Africa, and Asia.
Subscribe to our thought leadership
today and explore our products and
services at:
http:://thinking.nexant.com/

Nexant Headquarters
Nexant, Inc.
Tel: +1 415 369 1000
101 2nd St Suite 1000
San Francisco
CA 94105-3651
USA

Europe, Middle East


& Africa
Nexant Limited
Tel: +44 20 7950 1600
1 Kings Arms Yard
London EC2R 7AF
United Kingdom

Americas
Nexant, Inc.
Tel: +1 914 609 0300
44 S Broadway, 4th Floor
White Plains
NY 10601-4425
USA

Asia Pacific
Nexant Asia Limited
Tel: +662 793 4600
22nd Floor, Rasa Tower I
555 Phahonyothin Road
Kwaeng Chatuchak
Khet Chatuchak
Bangkok 10900
Thailand

You might also like